Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury

Journal of Clinical Investigation

Volumn 97, Issue 4, 1996, Pages 963-970

  Shanley, Thomas P ^a   Peters, James L ^a   Jones, Michael L ^a   Chensue, Stephen W ^a   Kunkel, Steven L ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

IL 1Ra; IL 1 ; immune complexes; lung injury; neutrophils; TNF

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLAMMATION; LUNG ALVEOLITIS; LUNG INJURY; MALE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS;

EID: 0030068940     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118520     Document Type: Article

References (52)

1. Dinarello, C.A. 1991 Interleukin-1 and interleukin-1 antagonism. Blood. 77:1627-1652
2. Dinarello, C.A 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314-1325.
3. Arfors, K -E., C Lundberg, L. Lindbom, K. Lundberg, P.G. Beatty, and J.M. Harlan. 1987. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 69:338-340
4. Ulich, T.R , Y Songmei, K. Guo, J. del Castillo, S P. Eisenberg, and R.C. Thompson. 1991 The intratracheal administration of endotoxin and cytokines. III The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. Am. J. Pathol. 138:521-524
5. Smith, J., W. Urba, R. Steis, J. Janik, B. Fenton, W. Sharfman, K. Conlon, M. Sznol, S. Creekmore, N Wells, et al. 1990. Interleukin-1 alpha, results of a phase I toxicity and immunomodulatory trial. Proc Annu. Meet. Am Soc. Clin. Oncol. 9:A717.
6. Larrick, J.W. 1989 Native interleukin 1 inhibitors. Immunol. Today 10: 61-66.
7. Muchmore, A.V., and J.M. Decker. 1986. Uromodulin. an immunosuppressive 85-kilodalton glycoprotein isolated from human pregnancy urine is a high affinity ligand for recombinant interleukin-1α. J. Biol. Chem. 261:13404-13407
8. Seckinger, P., J.W. Lowenthal, K. Williamson, J.-M. Dayer, and H.R. MacDonald. 1987. A urine inhibitor of interleukin 1 activity that blocks ligand binding. J. Immunol 139:1546-1549.
9. Eisenberg, S.P., R J. Evans, W P. Arend, E. Verderber, M.J. Brewer, C.H. Hannum, and R.C. Thompson. 1990. Primary structure and functional expression from complimentary DNA of a human interleukin-1 receptor antagonist. Nature (Lond). 343:341-346.
10. Hannum, C.H., C.J. Wilcox, W.P. Arend, F.G. Joslin, D.J. Dripps, P.L. Heimdal, L.G. Armes, A. Sommer, S P. Eisenberg, and R.C. Thompson. 1990 Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (Lond) 343:336-340.
11. Carter, D B., M.R. Deibel, C J. Dunn, C C. Tomich, A L Laborde, J.L Slightom, A.E. Berger, M.J. Bienkowski, F.F. Sun, R.N. McEwan, et al. 1990. Purification, cloning, expression and biologic characterization of an interleukin-1 receptor antagonist protein Nature (Lond.). 344:633-638.
12. Rochemonteix, B.G., L P. Nicod, R. Chicheportiche, S. Lacraz, C. Baumberger. and J.-M. Dayer. 1993 Regulation of interleukin-1ra, interleukin-1α, and interleukin-1β production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide, and interleukin-4. Am. J. Respir. Cell Moi Biol. 8.160-168.
13. Warren, J.S. 1991. Intrapulmonary interleukin-1 mediates acute immune complex alveolitis in the rat. Biochem. Biophys. Res. Commun. 175:604-610.
14. Arend, W.P., F.G. Joslin, R.C. Thompson, and C.H. Hannum. 1989 An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties J. Immunol. 143:31851-31858
15. Shanley, T.P., H. Schmal, H.P. Friedl, M.L Jones, and P.A. Ward 1995 Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J. Immunol. 154:3454-3460.
16. Mulligan, M.S., J.M. Hevel, M.A Marletta, and P.A. Ward. 1991. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl. Acad Sci USA. 88:6338-6342
17. Eisenberg, S.P., M.T. Brewer, E. Verderber, P. Heimdal, B.J. Brandhuber, and R.C. Thompson 1991. Interleukin-1 receptor antagonist is a member of the interleukin gene family, evolution of a cytokine control mechanism. Proc. Natl Acad. Sci. USA 88:5232-5236.
18. Chirgwin, J M., A.E. Pryzbyla, R.J MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
19. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature (Lond ). 227:680-685.
20. Warren, J.S., K.R. Yabroff, D.G. Remick, S.L. Kunkel, S W Chensue, R.G. Kunkel, K.J. Johnson, and P.A. Ward. 1989. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84:1873-1882.
21. Gubler, U., A.O. Chua, A.S. Stern, C P. Hellmann, M.P. Vitek, T.M. DeChiara, W.R. Benjamin, K.J. Collier, M. Dukovich, P.C. Familletti, et al. 1986 Recombinant human interleukin-1α: purification and biological characterization. J. Immunol. 136:2492-2497.
22. Arend, W.P., F.G. Joslin, and R.J. Massoni. 1985. Effects of immune complexes on production by human monocyles of interleukin-1 or interleukin-1 inhibitor(s). J. Clin. Invest. 78:1120-1124.
23. Dripps, D.J., B.J. Brandhuler, R.C. Thompson, and S.P Eisenberg. 1991. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate signal transduction. J. Biol. Chem 266:10331-10336
24. Dinarello, C A , and R.C. Thompson. 1991. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12:404-410.
25. Arend, W.P. 1991. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin. Invest. 88:1445-1451.
26. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hegeman, and R.C. Thompson 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (Lond.). 348:550-552.
27. Alexander, H.R., G.M Doherty, C.M. Buresh, D J. Venzon, and J.A. Norton. 1991. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice J. Exp. Med 173:1029-1032.
28. Fischer E., K J. Van Zee, M.A. Marano, C.S. Rock, J S. Kenney, D.D Poutsiaka, C.A. Dinarello, S.F. Lowry, and L L. Moldawer. 1992. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood. 79:2196-2200.
29. Mulligan, M.S , and P A. Ward. 1992. Immune complex-induced lung and dermal vascular injury: differing requirements for TNF-α and IL-1. J. Immunol 149:331-339.
30. Chensue, S.W., M. Bienkowski, T E Eessalu, K.S. Warmington, S.D Hershey, N.W Lukacs, and S.L. Kunkel. 1993. Endogenous IL-1 receptor antagonist protein (IL-1Ra) regulates schistosome egg granuloma formation and the regional lymphoid response. J. Immunol. 151:3654-3662.
31. Cominelli, F., C.C. Nast, A. Duchini, and M. Lee. 1992. Recombinant interleukin-1 receptor antagonist blocks the activity of endogenous interleukin-1 in rabbit immune colitis Gastroenterology 103:65-71.
32. Ferretti, M., V. Casini-Raggi, T.T. Pizarro, S.P Eisenberg, C.C Nast. and F Commelli. 1994. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest. 94:449-453.
33. Marsh, C.B., S.A. Moore, H.A. Pope, and M.D Wewers. 1994. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes. Am. J Physiol. 267:L39-L45.
34. Fischer, E., M.A Marano, K.J. van Zee, C.S. Rook, A.S. Hawes, W A Thompson, L DeForge, J.S. Kenney, D.G. Remick, D.C. Bloedow, et al. 1992 Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89:1551-1557.
35. Mulligan, M.S., M. Howard, M.L. Jones, and P.A. Ward. 1993. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 151:5666-5674.
36. Cannon, J.G., R.G. Tompkins, J.A. Gelfand, H.R. Michie, G.G. Stanford, J W.M van der Meer, S Endres, G. Lonnemann, J. Corsetti, H. Chernow, et al. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect Dis. 161:79-84
37. Michie, H.R., K.R. Monague, D.R. Spriggs, A. Revhaug, S. O'Dwyer, C.A. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl J. Med 318:1481-1486.
38. Hesse, D.G., K.J Tracey, Y Fong, K.R Manogue, M A. Palladino, A Cerami, G.T. Shives, and S F. Lowry 1988. Cytokine appearances in human endotoxemia and primate bacteremia. Surg. Gynecol. & Obstet. 166:147-153.
39. Kline, J.N , M.M. Monick, and G.W. Hunninghake. 1992. IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes. J. Appl. Physiol. 73:1686-1602.
40. Marsh, C.B., and M. Wewers. 1994. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes. Am. J. Respir. Cell Mol Biol 10:521-525.
41. Moore, S.A., R.M. Stricter, M.W. Rolfe, T.J. Standiford, M.D. Burdick, and S.L Kunkel. 1992. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol Biol 6:569-575.
42. Malyak, M., M.F. Smith, A.A Abel, and W.P. Arend. 1994 Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin 1β. J Clin. Invest. 14:20-30.
43. Chang, D.M. 1995. Cellular signals for the induction of human interleukin-1 receptor antagonist. Clin. Immunol. Immunopathol. 74:23-30
44. Malyak, M., R.E. Swaney, and W.P. Arend. 1993. Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: potential contribution from synovial fluid neutrophils. Arthritis & Rheum. 36:781-789.
45. Sone, S., E. Orino, S. Yano, Y. Nishioka, T. Haku, A. Nii, and T Ogura. 1994. Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages. Eur Respir. J. 7.657-663.
46. Cassatella, M.A., L. Meda, S Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclcar leukocytes by delaying mRNA degradation. J. Exp Med. 179:1695-1696.
47. Jenkins, J.K., M. Malyak, and W.P. Arend. 1994. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13.47-54.
48. Haskill, S , G. Martin, L. Van Le, J. Morris, A. Peace, C.F Bigler, G J Jaffe, C Hammerberg, S.A. Sporn, S. Fong, W.P. Arend, and P. Ralph. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad Sci. USA. 88:3681-3685.
49. Suter, P.M., S. Suter, E. Girardin, P. Roux-Lombard, G.E. Grau, and J.-M. Dayer. 1991. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir Dis. 145. 1016-1022.
50. Siler, T.M., J.E. Swierkosz, T M. Hyers, A.A. Fowler, and R.O. Webster. 1989. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome Exp Lung Res. 15:881-894.
51. Jacobs, R.F., D.R. Tabor, A.W. Burks, and G.D. Campbell. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome Am. Rev. Respir. Dis 140:1686-1692
52. Roumen, R.M., T. Hendriks, J. van der Ven-Jongekrig, G.A.P. Nieuwenhuijzen, R.W Sauerwein, J.W.M. van der Meer, and R.J.A. Goris. 1993. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 218:769-776.